GlaxoSmithKline Pharmaceuticals Limited Share Price NSE India S.E.
Equities
GLAXO
INE159A01016
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,360 INR | +3.17% | +18.02% | +24.31% |
Sales 2024 | 34.54B 415M 32.66B | Sales 2025 * | 36.49B 438M 34.51B | Capitalization | 388B 4.66B 367B |
---|---|---|---|---|---|
Net income 2024 | 5.9B 70.86M 5.58B | Net income 2025 * | 7.68B 92.21M 7.26B | EV / Sales 2024 | 9.53 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 10.6 x |
P/E ratio 2024 |
55.8
x | P/E ratio 2025 * |
50.6
x | Employees | 3,680 |
Yield 2024 * |
1.32% | Yield 2025 * |
1.38% | Free-Float | 24.42% |
1 day | +3.17% | ||
1 week | +18.02% | ||
Current month | +13.07% | ||
1 month | +24.97% | ||
3 months | +4.60% | ||
6 months | +43.18% | ||
Current year | +24.31% |
Managers | Title | Age | Since |
---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 54 | 30/11/22 |
Juby Chandy
DFI | Director of Finance/CFO | - | 31/03/22 |
Simrat Sohal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 70 | 31/03/19 |
Manu Anand
BRD | Director/Board Member | 64 | 15/05/22 |
Director/Board Member | 74 | 29/03/15 |
Date | Price | Change | Volume |
---|---|---|---|
18/05/24 | 2,360 | +3.17% | 126 099 |
17/05/24 | 2,287 | +13.08% | 1,198,663 |
16/05/24 | 2,022 | +1.68% | 110,541 |
15/05/24 | 1,989 | -0.27% | 84,411 |
14/05/24 | 1,994 | -0.25% | 36,943 |
Delayed Quote NSE India S.E., May 18, 2024 at 08:17 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- GLAXO Stock
- GLAXO Stock